Suchergebnisse - "Molica, Matteo"

PubPharm (162)

1

Luspatercept in low-risk myelodysplastic syndromes : a paradigm shift in treatment strategies

enthalten in: Expert opinion on biological therapy | 2024

von Molica, M. | Rossi, M.

2

Venetoclax : A Game Changer in the Treatment of Younger AML Patients?

enthalten in: Cancers | 2023

von Molica, M. | Perrone, S. | Federico, V. | +3

3

Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia : State of the Art and Recent Advances

enthalten in: Cancers | 2023

von Canichella, M. | Molica, M. | Mazzone, C. | +1

4

Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia

enthalten in: American journal of hematology | 2023

von Kadia, T. | Ravandi, F. | Molica, M. | +21

5

Gilteritinib and the risk of intracranial hemorrhage : a case series of a possible, under-reported side effect

enthalten in: Annals of hematology | 2023

von Perrone, S. | Imperatore, S. | Sucato, G. | +6

6

Immunotherapy of Acute Myeloid Leukemia: A Work in Progress

enthalten in: Preprints.org | 2023

von Molica, M. | Perrone, S. | Rossi, M.

7

Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia : A Work in Progress

enthalten in: Cancers | 2023

von Molica, M. | Perrone, S. | Andriola, C. | +1

8

Gilteritinib: The Story of a Proceeding Success into Hard-to-Treat FLT3 Mutated AML Patients

enthalten in: Preprints.org | 2023

von Molica, M. | Perrone, S. | Rossi, M.

9

Gilteritinib : The Story of a Proceeding Success into Hard-to-Treat FLT3-Mutated AML Patients

enthalten in: Journal of clinical medicine | 2023

von Molica, M. | Perrone, S. | Rossi, M.

10

TP53 mutations in therapy-related acute myeloid leukemia : still the dark side of the moon?

enthalten in: Polish archives of internal medicine | 2023

von Molica, M. | Rossi, M.

CommentOn: Pol Arch Intern Med. 2023 Jan 24;133(1):. - PMID 36165652

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]